Product Description

🔹 Product Overview
Bracanat 150 mg Tablet is a prescription targeted anticancer medicine used for the treatment of specific cancers associated with BRCA gene mutations and other DNA repair defects.
Contains Olaparib 150 mg, a potent PARP (Poly ADP-Ribose Polymerase) inhibitor that helps slow the growth and spread of cancer cells.
Commonly prescribed as part of treatment or maintenance therapy for selected cancer patients under specialist oncology supervision.

🔹 Key Uses
Treatment of ovarian cancer
Management of breast cancer
Treatment of pancreatic cancer
Management of prostate cancer
Maintenance therapy in patients with BRCA-mutated cancers and related genetic abnormalities.

🔹 Composition
Active ingredient: Olaparib 150 mg
Belongs to the PARP inhibitor class
Used in targeted oncology therapy.

🔹 How It Works
Blocks PARP enzymes responsible for repairing damaged DNA in cells.
Prevents cancer cells from repairing genetic damage.
Promotes cancer cell death and helps slow disease progression.

🔹 Key Benefits
Advanced targeted cancer therapy
Helps delay cancer progression in eligible patients
Supports long-term cancer management strategies
Oral tablet formulation for convenient administration
Widely used in personalized oncology treatment programs.

🔹 Dosage and Administration
Take exactly as prescribed by an oncologist.
Swallow tablets whole with water.
Can be taken with or without food.
Do not crush, chew, or split the tablets.
Regular medical monitoring and blood tests may be required during treatment.

🔹 Possible Side Effects
Nausea
Fatigue
Vomiting
Diarrhea
Loss of appetite
Dizziness
Anemia
Low blood cell counts.

🔹 Precautions
Use only under specialist oncology supervision.
Avoid pregnancy during treatment and use effective contraception if advised.
Inform your doctor about liver, kidney, or lung disorders.
Avoid grapefruit and grapefruit juice unless approved by your physician.
Report unusual bleeding, infections, or severe fatigue promptly.